United Kingdom - English - myHealthbox

brown & burk uk ltd - irbesartan - film-coated tablets - 150mg - angiotensin-ii antagonists, plain - it is indicated in adults for the treatment of essential hypertension. it is also indicated for the treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen

United Kingdom - English - myHealthbox

brown & burk uk ltd - irbesartan - film-coated tablet - 75mg - angiotensin-ii antagonists, plain - it is indicated in adults for the treatment of essential hypertension. it is also indicated for the treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen

United Kingdom - English - myHealthbox

brown & burk uk ltd - irbesartan - film-coated tablets - 300mg - angiotensin-ii antagonists, plain - it is indicated in adults for the treatment of essential hypertension. it is also indicated for the treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen

United Kingdom - English - myHealthbox

dr. reddy’s laboratories (uk) ltd. - bosentan - film-coated tablet - 62.5mg - other antihypertensives - treatment of pulmonary arterial hypertension (pah) to improve exercise capacity and symptoms in patients with who functional class iii. efficacy has been shown in: • primary (idiopathic and heritable) pulmonary arterial hypertension • pulmonary arterial hypertension secondary to scleroderma without significant interstitial pulmonary disease • pulmonary arterial hypertension associated with congenital systemic-topulmonary shunts and eisenmenger’s physiology

United Kingdom - English - myHealthbox

dr. reddy’s laboratories (uk) ltd. - bosentan - film-coated tablet - 125mg - other antihypertensives - treatment of pulmonary arterial hypertension (pah) to improve exercise capacity and symptoms in patients with who functional class iii. efficacy has been shown in: • primary (idiopathic and heritable) pulmonary arterial hypertension • pulmonary arterial hypertension secondary to scleroderma without significant interstitial pulmonary disease • pulmonary arterial hypertension associated with congenital systemic-topulmonary shunts and eisenmenger’s physiology

United Kingdom - English - myHealthbox

brown & burk uk ltd - lisinopril dihydrate - tablets - 2.5mg - ace inhibitor - hypertension: all grades of essential and renovascular hypertension. lisinopril tablets may be used alone or with other antihypertensives. congestive heart failure: lisinopril may be taken as an additional treatment with non-potassium-sparing diuretics and, where appropriate digoxin or digitoxin. commencement of lisinopril treatment should be under close medical supervision. severe heart failure should be treated in hospital. acute myocardial infarction: lisinopril may be used to treat haemodynamically stable patients (ie who are not in cardiogenic shock and who have a systolic blood pressure greater than 100 mmhg). lisinopril can be given within 24 hours of acute myocardial infarction to prevent left ventricular dysfunction, heart failure, and to increase survival prospects. patients should also receive the standard recommended treatments for this condition, ie aspirin, a beta-blocker and thrombolytics.

United Kingdom - English - myHealthbox

brown & burk uk ltd - lisinopril dihydrate - tablets - 10mg - ace inhibitor - hypertension: all grades of essential and renovascular hypertension. lisinopril tablets may be used alone or with other antihypertensives. congestive heart failure: lisinopril may be taken as an additional treatment with nonpotassium-sparing diuretics and, where appropriate digoxin or digitoxin. commencement of lisinopril treatment should be under close medical supervision. severe heart failure should be treated in hospital. acute myocardial infarction: lisinopril may be used to treat haemodynamically stable patients (ie who are not in cardiogenic shock and who have a systolic blood pressure greater than 100 mmhg). lisinopril can be given within 24 hours of acute myocardial infarction to prevent left ventricular dysfunction, heart failure, and to increase survival prospects. patients should also receive the standard recommended treatments for this condition, ie aspirin, a beta-blocker and thrombolytics.

United Kingdom - English - myHealthbox

brown & burk uk ltd - lisinopril dihydrate - tablets - 5mg - ace inhibitor - hypertension: all grades of essential and renovascular hypertension. lisinopril tablets may be used alone or with other antihypertensives. congestive heart failure: lisinopril may be taken as an additional treatment with nonpotassium-sparing diuretics and, where appropriate digoxin or digitoxin. commencement of lisinopril treatment should be under close medical supervision. severe heart failure should be treated in hospital. acute myocardial infarction: lisinopril may be used to treat haemodynamically stable patients (ie who are not in cardiogenic shock and who have a systolic blood pressure greater than 100 mmhg). lisinopril can be given within 24 hours of acute myocardial infarction to prevent left ventricular dysfunction, heart failure, and to increase survival prospects. patients should also receive the standard recommended treatments for this condition, ie aspirin, a beta-blocker and thrombolytics.

United Kingdom - English - myHealthbox

brown & burk uk ltd - lisinopril dihydrate - tablets - 20mg - ace inhibitor - hypertension: all grades of essential and renovascular hypertension. lisinopril tablets may be used alone or with other antihypertensives. congestive heart failure: lisinopril may be taken as an additional treatment with nonpotassium-sparing diuretics and, where appropriate digoxin or digitoxin. commencement of lisinopril treatment should be under close medical supervision. severe heart failure should be treated in hospital. acute myocardial infarction: lisinopril may be used to treat haemodynamically stable patients (ie who are not in cardiogenic shock and who have a systolic blood pressure greater than 100 mmhg). lisinopril can be given within 24 hours of acute myocardial infarction to prevent left ventricular dysfunction, heart failure, and to increase survival prospects. patients should also receive the standard recommended treatments for this condition, ie aspirin, a beta-blocker and thrombolytics.

United Kingdom - English - myHealthbox

dr. reddy’s laboratories (uk) ltd - docetaxel - concentrate for solution for infusion (sterile concentrate) - 20mg/ml - taxanes - in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with: • operable node-positive breast cancer • operable node-negative breast cancer.